The PROXIDRUGS consortium actively took part in the EMBO Workshop “Cancer cell signaling: Linking molecular knowledge on cancer therapy” which took place from 16 th to 20th September 2022 in Cavtat, Croatia. PROXIDRUGS speaker Ivan Dikic served as organizer, and several consortium members either presented as invited speaker or contributed posters. An entire session was dedicated to targeting cancer by PROTACs, immunotherapy and precision oncology, in part supported by PROXIDRUGS, and featuring renowned speakers in the field.
top of page
bottom of page